Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.

CONCLUSION: Early ADT at the PSA level of less than 2 ng/mL confers CSS benefits in patients with localized or locally advanced PCa who were previously treated with RP. PMID: 32734728 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32734728?dopt=Abstract

Source: Yonsei Medical Journal - July 31, 2020 Category: Universities & Medical Training Authors: Ahn HK, Lee KS, Kim D, Rha KH, Hong SJ, Chung BH, Koo KC Tags: Yonsei Med J Source Type: research